A predictive scoring instrument for tuberculosis lost to follow-up outcome

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Rodrigo, Teresa ^a,b,c,l   Caylà, Joan A ^a,b,c,l   Casals, Martí ^a,l,o   García García, José M ^a,d   Caminero, José A ^a,e,n   Ruiz Manzano, Juan ^a,f,m   Blanquer, Rafael ^a,g   Vidal, Rafael ^a,h,m   Altet, Neus ^a,i   Calpe, José L ^a,j   Penas, Antón ^a,k   Anibarro, L ^p   Alvarez F ^d   Barron M ^q   Bustamante, A ^r   Canas F ^r   Cases, E ^s   De Souza, M L ^t   Gallardo, J ^u   Gallego, M ^v   Garcia F J ^w   Gullon J A ^d   Jimenez M A ^t   Lloret, T ^x   Marin M ^y   Martinez A ^z   Medina, J F ^aa   Melero, C ^ab   Mila C ^t   Mir, I ^ac   Moreno, V ^ad   Valencia, E ^ad   Munoz C ^x   Pascual, T ^ae   Sanchez P ^af   Sande, D ^p   Vargas, A ^ag   more..

^a Programa Integrado de Investigacion en Tuberculosis   (Spain)

^b Unidad de Tuberculosis   (Spain)

^c Hospital Universitario Dr Peset de Valencia   (Spain)

^d HOSPITAL SAN AGUSTÍN   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ Unidad de Prevención y Control de Tuberculosis de Barcelona   (Spain)

^j HOSPITAL MARINA BAIXA   (Spain)

^k HOSPITAL XERAL CALDE   (Spain)

^l CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^m INSTITUTO DE SALUD CARLOS III   (Spain)

ⁿ INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^o UNIVERSITY OF BARCELONA   (Spain)

^p Unidad de Tuberculosis de Pontevedra   (Spain)

^q HOSPITAL SAN PEDRO   (Spain)

^r H Sierrallana ^*  (Spain)

^s H Universitario La Fe   (Spain)

^t Unidad Prevención y Control Tuberculosis   (Spain)

^u H de Guadalajara   (Spain)

^v Servicio de Oncología Médica   (Spain)

^w HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^x UNIVERSITY OF VALENCIA   (Spain)

^y University General Hospital of Castellon   (Spain)

^z H Marina Baixa de Alicante   (Spain)

^aa HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^ab HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^ac HOSPITAL SON LLÀTZER   (Spain)

^ad H Carlos III   (Spain)

^ae H de Cabueñes   (Spain)

^af H del Mar   (Spain)

^ag Surgery Unit Universitary Hospital Puerto Real   (Spain)

more..

Author keywords

Adherence; Lost to follow up outcome; Predictors; Scoring system; Tuberculosis

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMPREHENSION; FEMALE; FOLLOW UP; HUMAN; IMMIGRATION; INDEPENDENT LIVING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; TUBERCULOSIS; ADOLESCENT; AGED; ALGORITHM; MARRIAGE; MIDDLE AGED; MIGRATION; PATIENT SELECTION; SPAIN; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; LOST TO FOLLOW-UP; MALE; MARITAL STATUS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; SPAIN; TUBERCULOSIS; YOUNG ADULT;

EID: 84865534492     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-75     Document Type: Article

References (33)

1. Frieden TR, Teklehaimanot A, Chideya S, Farmer P, Kim JY, Raviglione MC. A road map to control malaria, tuberculosis, and human immunodeficiency Virus/AIDS. Arch Intern Med 2009, 169(18):1650-1652. Available in: www.archinternmed.com..
2. Kochi A, Bumgarner R, Spinaci S, Kumaresan J, Raviglioni M, Hanson C. What is DOTS? A guide to understanding the WHO-recommended tuberculosis control strategy know as DOTs 1999, Ginebra: World Health Organization.
3. The Stop TB Strategy Building on and enhancing DOTS to meetthe TB-related Millennium Development Goals 2006, Genova: World Health Organization, The Stop TB Strategy.
4. Juan G, Lloret T, Pérez C, López P, Navarro R, Ramón M, Cortijo J, Morcillo EJ. Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain. Int J Tuberc Lung Dis 2006, 10(2):215-221.
5. Snyder DC, Chin DP. Cost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default. Am J Respir Crit Care Med 1999, 160:582-586.
6. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Masaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008, 117:743-753.
7. Zachariah R, Harries AD, Srinath S, Ram S, Viney K, Singogo E, Lal P, Mendoza-Ticona A, Sreenivas A, Aung NW, Sharath BN, Kanyerere H, van Soelen N, Kirui N, Ali E, Hinderaker SG, Bissell K, Enarson DA, Edginton ME. Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients?. Int J Tuberc Lung Dis 2012, 16(6):714-717.
8. van Hest NAH, Ködmön C, Verver S, Erkens CGM, Straetemans M, Manissero D, de Vries G. Tuberculosis treatment outcome monitoring in European Union countries: systematic review. ERJ Express 2012,
9. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic test and procedures: principles and applications. Ann Intern Med 1981, 94(part2):553-600.
10. Stevenson M, Nunes T, Sánchez J, Thornton R. EpiR: Functions for analysing epidemiological data. R package version 0.9-27 2010, Available in: http://CRAN.R-project.org/package=epiR. Accessed 2012 May 20..
11. Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007, 11(1):46-53.
12. Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M. Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Publ Health 2012, 12:56.
13. da Silva Garrido M, Penna ML, Perez-Porcuna TM, Brito de Souza A, da Silva Marreiro L, Albuquerque BC, Martínez-Espinosa FE, Bührer-Sékula S. Factors associated with tuberculosis treatment default in an endemic area of the brazilian amazon: a Case Control-Study. PLoS One 2012, 7(6):e39134.
14. Pocock SJ, McCormack V, Gueyffier S, Boutitie F, Fagard RH, Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001, 323:75-81.
15. Lemeshow S, Teres D, Klar J, Spitz Avrunin J, Gehlbach SH, Rapoport J. Mortality Probability Models (MPM II) Based on an International Cohort of Intensive Care Unit Patients. JAMA 1993, 270(20):2478-2486.
16. Barquet N, Domingo P, Caylà JA. Factores pronósticos en la enfermedad meningocócica. Elaboración de un modelo predictivo y de un sistema de puntuación aplicable en la cabecera del paciente. JAMA 1998, 7(2):41-47.
17. van Dijk WD, van den Bemt L, van den Haak-Rongen S, Bischoff E, Chris van Weel C, in 't Veen JCCM, RJ Schermer T. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respiratory Research 2011, 12:151. Available in: http://respiratory-research.com/content/pdf/1465-9921-12-151.pdf..
18. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, Weis SE. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 2007, 132:1591-1598.
19. Rakoczy KS, Cohen SH, Nguyen HH. Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol 2008, 29(10):927-932.
20. Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogumuller G, Wilks MJ, Waramori G, Tjitra E, Sandjaja, Kenagalem E, Pontororing GJ, Anstey NM, Kelly PM. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 2010, 65(10):863-869.
21. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, Sodemann M. TBscoCre: signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2008, 40(2):111-120.
22. Martínez D, Heudebert G, Seas C, Henostroza G, Rodríguez M, Zamudio C, Centor RM, Herrera C, Gotuzzo E, Estrada C. Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis. PLoS One 2010, 5(8):e12082.
23. Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M, . Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE) Tuberculosis treatment adherence and fatality in Spain. Respir Res 2009, 10:121. Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE).
24. García-García JM, Blanquer R, Rodrigo T, Caylà JA, Caminero JA, Vidal R, Casals M, Ruiz-Manzano J, . Working Group on Completion of Tuberculosis Treatment in Spain (ECUTTE Study) Social, clinical and microbiological differential characteristics of tuberculosis among immigrants in Spain. PLoS One 2011, 6(1):e16272. Working Group on Completion of Tuberculosis Treatment in Spain (ECUTTE Study).
25. Coker R, Bell A, Pitman R, Zellweger JP, Heldal E, Hayward1 A, Skulberge A, Bothamley G, Whitfield R, de Vries G, Watson JM. Tuberculosis screening in migrants inselected European countries shows wide disparities. Eur Respir J 2006, 27:801-807.
26. Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA. The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis 2009, 13(5):645-651.
27. Gany FM, Trinh-Shevrin C, Changrani J. Drive-by readings: a creative strategy for tuberculosis control among immigrants. Am J Public Health 2005, 95(1):117-119.
28. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS One 2007, 4(7):e238.
29. Caylà JA, Caminero JA, Rey R, Lara N, Vallés X, Galdós-Tangüis H, . Working Group on Completion of Tuberculosis Treatment in Spain Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004, 8(4):458-464. Working Group on Completion of Tuberculosis Treatment in Spain.
30. Burman WJ, Cohn D, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves R. Non-compliance with directly observed therapy for Tuberculosis. Chest 1997, 111:1168-1173.
31. Cayla JA, Orcau A. The control of tuberculosis in large cities in developed countries; an organisational problem. BMC Medicine 2011, 9:127. Available in: http://www.biomedcentral.com/1741-7015/9/127..
32. Jasmer RM, Seaman CB, González LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis treatment outcomes. directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004, 170:561-566.
33. Rodrigo T, Caylà JA, García de Olalla P, Brugal MT, Jansà JM, Guerrero R, Marco A, Martín V. Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000. Int J Tuberc Lung Dis 2002, 6(12):1091-1097.